IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

Market Open
16 Oct, 02:51 PM
NYSE NYSE
$
269. 59
-1.45
-0.535%
$
42.91B Market Cap
38.04 P/E Ratio
- Div Yield
173,741 Volume
10.19 Eps
$ 271.04
Previous Close
Add Transaction
Day Range
267.99 272.88
Year Range
154.5 277.4
Want to track IQV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seekingalpha | 4 months ago
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?

Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?

VEEV and IQV are benefiting from life sciences digitization trends, but differences in growth, AI adoption and valuation set them apart.

Zacks | 4 months ago
Here's Why Investors Must Hold IQV Stock in Their Portfolios for Now

Here's Why Investors Must Hold IQV Stock in Their Portfolios for Now

IQVIA's record $34.2B backlog, AI-led pharma demand and $1.24B buybacks support growth despite weak liquidity and no dividend.

Zacks | 4 months ago
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term

Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 4 months ago
IQVIA: The Market May Be Missing The AI & Data Story

IQVIA: The Market May Be Missing The AI & Data Story

IQVIA earns a Buy rating as the market underappreciates its AI-driven Commercial Solutions segment and unique healthcare data assets. AI is a tailwind, not a threat, with 19 of the top 20 pharma companies using IQV's AI agents and workflows. Commercial Solutions segment grew 11.6% year-over-year, outpacing the traditional CRO segment and driving margin expansion.

Seekingalpha | 4 months ago
IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 5 months ago
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 5 months ago
IQVIA Q1 Earnings Call Highlights

IQVIA Q1 Earnings Call Highlights

IQVIA NYSE: IQV reported record first-quarter revenue and adjusted diluted earnings per share for 2026, with management citing accelerating organic growth across its Commercial Solutions and R&D Solutions businesses, increased demand tied to artificial intelligence offerings and continued strength in forward-looking clinical development metrics.

Marketbeat | 5 months ago
Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings

Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 5 months ago
IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

Seekingalpha | 5 months ago
IQV Q1 Earnings Beat on Commercial Solutions Strength

IQV Q1 Earnings Beat on Commercial Solutions Strength

IQVIA tops on Q1 EPS and revenues on strong Commercial Solutions growth, lifts its 2026 EPS outlook and keeps the revenue & EBITDA guidance steady.

Zacks | 5 months ago
Loading...
Load More